Observational study / 2012
Higher caffeine intake was associated with a reduced risk of Parkinson's disease in men, with a suggestive reduction in women.
In the prospective Cancer Prevention Study II Nutrition Cohort, caffeine intake was evaluated for its association with incident Parkinson's disease (PD). After adjusting for age, smoking, and alcohol intake, comparing the 5th to the 1st quintile of caffeine intake yielded a relative risk of 0.43 (95% CI: 0.26, 0.71; P trend < 0.002) in men and 0.61 (95% CI: 0.34, 1.09; P trend = 0.05) in women. Among women, the association was stronger in never users of hormone replacement therapy (RR = 0.32) than in ever users (RR = 0.81; P interaction = 0.15). Consumption of decaffeinated coffee was not associated with PD risk.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- Men and women from the CPS II Nutrition Cohort with 317 incident PD cases (197 men, 120 women)
- What was measured
- Incident cases of Parkinson's disease
THE PAPER
Caffeine and risk of Parkinson's disease in a large cohort of men and women.
Palacios N, Gao X, McCullough ML, Schwarzschild MA, Shah R, Gapstur S, Ascherio A. Mov Disord, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.